摘要:
A new class of indazole-derived bradykinin B-1 antagonists and their structure-activity relationships (SAR) is reported. A number of compounds were found to have low-nanomolar affinity for the human B-1 receptor and possess acceptable P-gp and pharmacokinetics properties. (C) 2010 Elsevier Ltd. All rights reserved.